Biovet JSC (LTS:0III) Total Liabilities: лв204.52 Mil (As of Dec. 2016)


What is Biovet JSC Total Liabilities?

Biovet JSC LTS:0III Total Liabilities is лв204.52 Mil as of Dec. 2016. The stock has 1 warning sign investors should review.

Biovet JSC's Total Liabilities for the quarter that ended in Dec. 2016 was лв204.52 Mil.

Biovet JSC's quarterly Total Liabilities increased from Jun. 2016 (лв170.41 Mil) to Sep. 2016 (лв185.74 Mil) and increased from Sep. 2016 (лв185.74 Mil) to Dec. 2016 (лв204.52 Mil).

Biovet JSC's annual Total Liabilities increased from Dec. 2014 (лв136.73 Mil) to Dec. 2015 (лв160.87 Mil) and increased from Dec. 2015 (лв160.87 Mil) to Dec. 2016 (лв204.52 Mil).

Biovet JSC Total Liabilities Historical Data

* Premium members only.

The historical data trend for Biovet JSC's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biovet JSC Total Liabilities Chart

Biovet JSC Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Total Liabilities
Get a 7-Day Free Trial 132.99 134.46 136.73 160.87 204.52

Biovet JSC Quarterly Data
Dec09 Dec10 Dec11 Dec12 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 160.87 170.28 170.41 185.74 204.52

Biovet JSC Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Biovet JSC's Total Liabilities for the fiscal year that ended in Dec. 2016 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=165.037+(34.588+4.096
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0.794+0)
=204.52

Total Liabilities=Total Assets (A: Dec. 2016 )-Total Equity (A: Dec. 2016 )
=336.286-131.771
=204.52

Biovet JSC's Total Liabilities for the quarter that ended in Dec. 2016 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=165.037+(34.588+4.096
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0.794+0)
=204.52

Total Liabilities=Total Assets (Q: Dec. 2016 )-Total Equity (Q: Dec. 2016 )
=336.286-131.771
=204.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of лв204.52 Mil mean?
Biovet JSC (LTS:0III) has a Total Liabilities of лв204.52 Mil as of Dec. 2016. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Biovet JSC and its competitors.
Is Biovet JSC's Total Liabilities too high?
Biovet JSC's current Total Liabilities is лв204.52 Mil.
How does Biovet JSC's Total Liabilities compare to ADMP and AGRX?
Biovet JSC's Total Liabilities of лв204.52 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Biovet JSC and its competitors. Biovet JSC's current Total Liabilities is лв204.52 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biovet JSC stock overvalued right now?
Biovet JSC (LTS:0III) has a current Total Liabilities of лв204.52 Mil. The current Total Liabilities is лв204.52 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Biovet JSC (LTS:0III), the current Total Liabilities is лв204.52 Mil as of Dec. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biovet JSC Business Description

Biovet JSC manufactures & markets medicated and nutritional feed additives, enzymes, bulk active substances & pharmaceuticals for animal productivity & health. It offers intermediates, active ingredients and medicines for human pharmaceutical industry.